Renaissance Technologies - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 69 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$154
-18.9%
148,199
+9.9%
0.00%
Q2 2023$190
-4.5%
134,799
+7.6%
0.00%
Q1 2023$199
-2.5%
125,299
-10.4%
0.00%
Q4 2022$204
-100.0%
139,787
+45.8%
0.00%
-100.0%
Q3 2022$409,000
+13.0%
95,899
+2.7%
0.00%
Q2 2022$362,000
+58.8%
93,399
+94.6%
0.00%
Q1 2022$228,000
-46.0%
48,000
-58.5%
0.00%
-100.0%
Q4 2021$422,000115,7000.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,120,0000.80%
Samsara BioCapital, LLC 689,709$2,676,0000.71%
BVF INC/IL 3,614,662$14,025,0000.68%
HAMILTON LANE ADVISORS LLC 71,491$277,0000.11%
MAI Capital Management 647,950$2,514,0000.05%
Laurion Capital Management LP 698,000$2,708,0000.04%
Jasper Ridge Partners, L.P. 92,939$361,0000.02%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$80,0000.02%
Ergoteles LLC 155,562$604,0000.02%
Clear Harbor Asset Management, LLC 25,000$97,0000.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders